» Articles » PMID: 19207586

Recurrence of Primary Biliary Cirrhosis and Development of Autoimmune Hepatitis After Liver Transplant: A Blind Histologic Study

Overview
Journal Hepatol Res
Specialty Gastroenterology
Date 2009 Feb 12
PMID 19207586
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This long-term study aimed to evaluate recurrence and evolution of primary biliary cirrhosis (PBC) after orthotopic liver transplantation (OLT).

Methods: We reviewed "blindly" allograft biopsy specimens of women who underwent transplantation for PBC (n = 84), and women who received a transplant for chronic hepatitis C virus infection (CHCV ) (n = 108). All needle liver biopsy specimens obtained more than 6 months post-OLT were examined, including 83 specimens from 44 PBC patients and 152 specimens from 58 CHCV patients.

Results: Granulomatous destructive cholangitis was found in five biopsies from four PBC patients (P = 0.0048). Non-necrotizing epithelioid cell granulomas were present in four biopsies from four PBC patients, and in two biopsies from one CHCV patient. Piecemeal necrosis (P = 0.0002), lobular necroinflammatory activity (P < 0.0001), steatosis (P < 0.0001) and fibrosis (P < 0.0001) were more prevalent in CHCV patients than PBC patients. Four PBC patients developed histologic evidence of autoimmune hepatitis (AIH), at a mean time of 3.66 years post-OLT. One of these patients had histologic features of AIH/PBC overlap syndrome. All four patients developed bridging fibrosis (n = 2) or cirrhosis (n = 2). No other PBC patient had evidence of cirrhosis after OLT.

Conclusions: Histologic findings indicative of recurrent PBC were present in 15.9% of the PBC patients undergoing biopsy in this series. However, this group of patients did not suffer significant bile duct loss or fibrosis, as compared to the control group, suggesting that recurrent PBC is a mild or slowly progressive disease. Histologic evidence of AIH was observed in allograft biopsies of some PBC patients.

Citing Articles

Current understanding of primary biliary cholangitis.

Tanaka A Clin Mol Hepatol. 2020; 27(1):1-21.

PMID: 33264835 PMC: 7820210. DOI: 10.3350/cmh.2020.0028.


Overlap syndromes: an emerging diagnostic and therapeutic challenge.

Dhiman P, Malhotra S Saudi J Gastroenterol. 2014; 20(6):342-9.

PMID: 25434314 PMC: 4271008. DOI: 10.4103/1319-3767.145316.


Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.

Czaja A Dig Dis Sci. 2012; 57(9):2248-66.

PMID: 22562533 DOI: 10.1007/s10620-012-2179-3.

References
1.
Heneghan M, Portmann B, Norris S, Williams R, Muiesan P, Rela M . Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology. 2001; 34(3):464-70. DOI: 10.1053/jhep.2001.26756. View

2.
Jacob D, Neumann U, Bahra M, Langrehr J, Neuhaus P . Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Transplant Proc. 2005; 37(4):1691-2. DOI: 10.1016/j.transproceed.2005.03.130. View

3.
Rodriguez-Diaz Y, Reyes-Rodriguez R, Dorta-Francisco M, Aguilera I, Perera-Molinero A, Moneva-Arce E . De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Transplant Proc. 2006; 38(5):1467-70. DOI: 10.1016/j.transproceed.2006.03.071. View

4.
Schreuder T, Hubscher S, Neuberger J . Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?. Transpl Int. 2008; 22(2):144-52. DOI: 10.1111/j.1432-2277.2008.00729.x. View

5.
Kotlyar D, Campbell M, Reddy K . Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol. 2006; 101(6):1370-8. DOI: 10.1111/j.1572-0241.2006.00586.x. View